This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy Policy.

Pipeline

Compound

Indication

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Endometriosis

HMI-115

Androgenic Alopecia

Third Indication

Decoy Receptor Protein

Diabetic foot ulcer

Therapeutic Protein Therapy

Myocardial infarction

GPCR antagonist

Cancer Cachexia

Kinase Inhibitor

Kinase Inhibitor

Enzyme Inhibitor

Chemotherapy Toxicity

Kinase Inhibitor

ARDS/Sepsis

HMI-115

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Endometriosis

Androgenic Alopecia

Third Indication

Decoy Receptor Protein

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Diabetic foot ulcer

Therapeutic Protein Therapy

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Myocardial infarction

GPCR antagonist

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Cancer Cachexia

Kinase Inhibitor

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Kinase Inhibitor

Enzyme Inhibitor

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

Chemotherapy Toxicity

Kinase Inhibitor

Exploratory

Lead Opt.

Non-clinical Dev.

Phase I

Phase II

ARDS/Sepsis

Follow Us

g_img1.png

Top